Skip to main content

Advertisement

Fig. 5 | Molecular Cancer

Fig. 5

From: miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer

Fig. 5

EGFR and miR-19b act together to control cell migration. Wound closure assay of (a) PC9 and (b) HCC4011 cells. Wound closure was monitored over a period of 24 h in the presence or absence of 0.625 μM gefitinib using the imaging system Cell-IQ. Gefitinib was added immediately after injury of the monolayer. Results are presented as mean ± SD (n = 6)

Back to article page